Literature DB >> 29155881

Correction: Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0183475.].

Entities:  

Year:  2017        PMID: 29155881      PMCID: PMC5695770          DOI: 10.1371/journal.pone.0188416

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The content in Table 1 is incorrectly duplicated. The publisher apologizes for the error. Please see the correct Table 1 here.
Table 1

Overview of the Heinrichs-Carpenter Quality of Life Scale (QLS) and Work Readiness Questionnaire (WoRQ).

QLSWoRQ
ObjectiveTo assess health-related quality of life and functioning in patients with schizophrenia during the preceding four weeks7To assess functional capacity to work and work readiness in patients with schizophrenia6
RaterClinicianClinician
DomainInterpersonal relationsInstrumental roleIntrapsychic foundationsaCommon objects and activities
PurposeTo examine a patient’s social experienceTo assess a patient’s work functioningTo assess a patient’s sense of purpose and motivationTo evaluate a patient’s level of participation in the community
Items1. Householda2. Friends3. Acquaintances4. Social activity5. Social network6. Social initiative7. Withdrawal8. Sociosexual9. Occupational role10. Work functioning11. Work level12. Work satisfactiona13. Sense of purpose14. Motivation15. Curiosity16. Anhedonia17. Aimless inactivity20. Empathy21. Emotional interaction18. Commonplace objects19. Commonplace activities1. The patient generally adheres to a treatment plan, including medication.2. The patient is able to carry out Activities of Daily Living.3. The patient is able to consistently keep appointments and schedules with only minimal assistance.4. The patient would have adequate impulse control when interacting with authority figures, peers or coworkers, and potential customers.5. The patient’s behavior would not make others uncomfortable in a work situation.6. The patient’s appearance would not make others uncomfortable in a work situation.7. The patient’s current symptoms would not interfere with the ability to hold a job.8. Based on your clinical judgment, is this patient ready for work?
ScoringEach item is rated on a 7-point scale, ranging from 0 (severe impairment) to 6 (normal or unimpaired functioning), and definitions are provided for 4 anchor points of the 7 points. Higher scores indicate a better quality of life and functioning, and QLS total scores thus ranges from 0–126.Each statement item is rated on a 4-point scale, ranging from 1 (strongly agree) to 4 (strongly disagree). In the final item 8, the clinician indicates if the patient is ready for work independent of the score in each item (Yes/No). WoRQ total score is the sum of items 1–7, and thus ranges from 7–28 with lower scores indicating better functioning.

a For domain scores and total scores, scores for patients who could not be rated on items 1 and 12 were prorated on the basis on the items 2–8 and items 9–11, respectively.

a For domain scores and total scores, scores for patients who could not be rated on items 1 and 12 were prorated on the basis on the items 2–8 and items 9–11, respectively.
  1 in total

1.  Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.

Authors:  Steven G Potkin; Jean-Yves Loze; Carlos Forray; Ross A Baker; Christophe Sapin; Timothy Peters-Strickland; Maud Beillat; Anna-Greta Nylander; Peter Hertel; Simon Nitschky Schmidt; Anders Ettrup; Anna Eramo; Karina Hansen; Dieter Naber
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

  1 in total
  1 in total

1.  Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.

Authors:  Ilaria Cuomo; Georgios D Kotzalidis; Simone de Persis; Daria Piacentino; Filippo Perrini; Emanuela Amici; Sergio De Filippis
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-21       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.